IL-12 as an adjuvant for Bordetella pertussis vaccines

Bordetella Bordetella Bordetella This invention provides a composition of at least one antigen and an effective adjuvant amount of interleukin-12 (IL-12), and uses thereof as a vaccine against infection. Methods for using IL-12 as an adjuvant in combination with vaccines against are also provided.

Saved in:
Bibliographic Details
Main Authors Mills, Kingston H. G, Mahon, Bernard P, Ryan, Mark S, Griffin, Fiona
Format Patent
LanguageEnglish
Published 16.08.2005
Online AccessGet full text

Cover

More Information
Summary:Bordetella Bordetella Bordetella This invention provides a composition of at least one antigen and an effective adjuvant amount of interleukin-12 (IL-12), and uses thereof as a vaccine against infection. Methods for using IL-12 as an adjuvant in combination with vaccines against are also provided.